Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Down – Should You Sell?

Eurofins Scient (OTCMKTS:ERFSF) shares gapped down before the market opened on Wednesday . The stock had previously closed at $81.76, but opened at $78.44. Eurofins Scient shares last traded at $81.11, with a volume of 145 shares traded.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. BNP Paribas raised shares of Eurofins Scient to an “outperform” rating in a research note on Monday. Citigroup reissued a “neutral” rating on shares of Eurofins Scient in a research note on Wednesday, October 22nd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Eurofins Scient in a research note on Wednesday, October 29th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold”.

Eurofins Scient Price Performance

The business has a fifty day moving average price of $70.32 and a two-hundred day moving average price of $72.96. The company has a current ratio of 1.26, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77.

Eurofins Scient Company Profile

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.